Author:
Nakayama I.,Takahari D.,Chin K.,Wakatsuki T.,Takamatsu M.,Yamamoto N.,Ogura M.,Ooki A.,Fukuda K.,Osumi H.,Fukuoka S.,Shinozaki E.,Yamaguchi K.
Reference27 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Lordick;Ann Oncol,2022
3. Japanese gastric cancer treatment guidelines 2018 (5th edition);Gastric Cancer,2021
4. Gastric Cancer, Version 2. 2022, NCCN Clinical Practice Guidelines in Oncology;Ajani;J Natl Compr Canc Netw,2022
5. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial;Janjigian;Lancet,2021